NCT06938815

A Novel Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 10 (actual)
• Sponsor: Narrows Institute for Biomedical Research · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a single-center, prospective, non-blinded, non-randomized 12 week clinical study to evaluate the efficacy of a SkinCeuticals comprehensive skin care regimen in the reduction of post inflammatory hyperpigmentation (PIH) in skin of color patients. The comprehensive regimen features the Pigment Balancing Peel which combines glycolic acid, lactic acid, kojic acid, vitamin C, and emblica into a treatment that may improve skin discoloration. Participants will supplement the Pigment Balancing Peel with a 11 week regimen that includes the Hydrating B5 Gel, Discoloration Defense, LHA Cleansing Gel, and Brightening UV Defense sunscreen.

Conditions

• Post Inflammatory Hyperpigmentation

Interventions

Type	Name	Description
OTHER	Pigment Balancing Peel	Chemical Peel
OTHER	Discoloration Defense Serum	Dark spot correcting serum
OTHER	LHA Cleansing Gel	exfoliating gel facial cleanser
OTHER	Hydrating B5 Gel	Vitamin B5 serum with hyaluronic acid
OTHER	Daily Brightening Sunscreen	daily moisturizing sunscreen SPF 30

Timeline

• Start date: 2025-02-28
• Primary completion: 2025-07-01
• Completion: 2025-07-20
• First posted: 2025-04-22
• Last updated: 2025-11-24

Locations

1 site across 1 country: United States